Since snapping up rare disease biopharma Shire for $62 billion back in 2019, Takeda has been boosting its marketing might on conditions not in the mainstream.
As we head for Rare Disease day on Feb. 28, Takeda’s U.K. unit is ramping up awareness for rare diseases in general, tapping Shanali Perera for a new piece of art to highlight conditions so rare they are too often hidden from view.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,